Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448077) titled 'Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Hebei Medical University Fourth Hospital
Condition:
Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer
Intervention:
Drug: Experimental: short-course radiotherapy and immunotherapy
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollm...